Synapse - Chau Dang

Search Within

Chau Dang

Results (272)

Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: A literature review

Review

Perez, E. A.; Dang, C.; Lee, C.; Singh, J.; Wang, K.; Layton, J. B.; Gilsenan, A.; Hackshaw, M. D.; Cortes, J.
Breast Cancer Research and Treatment (2022)

Fulltext@MSK | Save

Home cardiac surveillance with artificial intelligence digital patient monitoring during treatment with pertuzumab, trastuzumab and hyaluronidase-ZZXF for HER2-positive breast cancer (HARRIET): Study design and rationale

Meeting Abstract

Yu, A. F.; Ferraro, E.; Liu, J. E.; Advani, P.; Herrmann, J.; Yang, A.; Fung, A.; Day, B. M.; Xia, B.; Chacon, M.; more...
Journal of the American College of Cardiology (2022)

Fulltext@MSK | Save

Neoadjuvant chemotherapy for breast cancer in the elderly: Are we accomplishing our treatment goals?

Meeting Abstract

Williams, A. D.; Dang, C.; Sevilimedu, V.; Morrow, M.; Barrio, A. V.
Annals of Surgical Oncology (2022)

Fulltext@MSK | Save

Local therapy outcomes and toxicity from the ATEMPT trial (TBCRC 033): A phase II randomized trial of adjuvant trastuzumab emtansine versus paclitaxel in combination with trastuzumab in women with stage I HER2-positive breast cancer

Journal Article

Bellon, J. R.; Tayob, N.; Yang, D. D.; Tralins, J.; Dang, C. T.; Isakoff, S. J.; DeMeo, M.; Burstein, H. J.; Partridge, A. H.; Winer, E. P.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Quality of life following receipt of adjuvant chemotherapy with and without bevacizumab in patients with lymph node-positive and high-risk lymph node-negative breast cancer

Journal Article

Rosenberg, S. M.; O'Neill, A.; Sepucha, K.; Miller, K. D.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.; Schneider, B. P.; Partridge, A. H.
JAMA Network Open (2022)

Fulltext@MSK | Save

Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab

Journal Article

Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
npj Breast Cancer (2022)

Fulltext@MSK | Save

Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): A randomized controlled trial

Journal Article

Barroso-Sousa, R.; Tarantino, P.; Tayob, N.; Dang, C.; Yardley, D. A.; Isakoff, S. J.; Valero, V.; Faggen, M.; Mulvey, T.; Bose, R.; more...
npj Breast Cancer (2022)

Fulltext@MSK | Save

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer

Journal Article

Sparano, J. A.; O’Neill, A.; Graham, N.; Northfelt, D. W.; Dang, C. T.; Wolff, A. C.; Sledge, G. W.; Miller, K. D.
npj Breast Cancer (2022)

Fulltext@MSK | Save

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial

Meeting Abstract

Sparano, J. A.; O'Neill, A. M.; Graham, N.; Northfelt, D. W.; Dang, C. T.; Wolff, A. C.; Sledge, G. W.; Miller, K.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)

Meeting Abstract

Wang, R.; Singh, J. C.; Wong, S. T. L.; Lake, D.; Iyengar, N. M.; D'Andrea, G.; Brockway-Marchello, J. P.; Kaba, A.; Traina, T. A.; Robson, M. E.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save